Respiratory Syncytial Virus Clinical Trials

Home | Studies | Respiratory Syncytial Virus Clinical Trials

A Chance for Healthy People to Volunteer in Clinical Research

Participate In Respiratory Syncytial Virus Clinical Trials in Michigan!

Respiratory Syncytial Virus (RSV) is a common respiratory infection that can lead to serious complications, particularly in older adults and individuals with underlying health conditions. It can cause symptoms such as persistent cough, wheezing, and difficulty breathing, often making everyday activities more challenging.

Revival Research Institute is conducting a clinical trial to evaluate a potential new treatment for respiratory syncytial virus clinical trials in healthy individuals. If you or someone you know is in good health and interested in contributing to the advancement of RSV prevention, you may be eligible to participate.

You may qualify for the respiratory syncytial virus Clinical Trials near you if you are:

Are ≥60 years of age
Healthy participants with medically confirmed good health status

*Additional criteria may apply

*Take part in paid Respiratory Syncytial Virus Clinical Trials at no cost to you or your medical insurance. You will be reimbursed financially for your time and travel. In addition, all participants receive study-related care from an experienced research team.

*If you are interested in participating in the Respiratory Syncytial Virus Clinical Trials in Michigan or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

State

How did you hear about us?*

Comments

User Agreement*

By checking this form, I consent to receiving SMS from Revival Research Institute, LLC.

General Communication Consent*

By checking this form, I consent to receiving phone calls from Revival Research Institute, LLC.

About Respiratory Syncytial Virus Vaccine Trials in Southfield, Michigan

Respiratory Syncytial Virus (RSV) is a common respiratory virus that can lead to serious complications, especially in older adults and individuals with weakened immune systems. Each year, RSV causes thousands of hospitalizations across the U.S., particularly during peak seasonal outbreaks.

As symptoms like persistent coughing, wheezing, or shortness of breath worsen, everyday activities such as walking, sleeping, or even talking can become difficult. The impact of RSV extends beyond physical symptoms. For older adults, RSV-related illness can disrupt routines, reduce independence, and contribute to prolonged recovery periods that affect overall well-being and quality of life.

Respiratory syncytial virus clinical trials will be conducted in several locations across the United States, including Michigan. To ensure study eligibility, all participants must comply with study procedures.

*There is no cost to you, your private medical insurance, or the public health insurance plan for study procedures. The study-related procedures, and visits will be provided at no charge throughout the duration of the study.

Get Started: What to Expect?

If you are interested and wants to participate in a paid respiratory syncytial virus clinical trial, please reach out to us by filling in the form above. One of our study team representatives will contact you to see if you are eligible for this study (pre-screening).

Someone from the research team will ask you to sign an Informed Consent Form (ICF) if you meet the study criteria during the pre-screening process. Once you sign up for the ICF, we will invite you for a screening visit to our clinical site; this will be an initial visit. After that, you will undergo a series of health-related questions and tests to confirm your eligibility as a participant.

Once you receive confirmation of eligibility, you will formally be a part of the respiratory syncytial virus clinical trial. You will receive all the information about the research study you might enroll in during the ICF process. We encourage you to ask as many questions as you would like before deciding to participate.

*All study-related care is provided free of cost. Complete physical examination and other study-related assessments will be done by expert physicians and health care experts.

No. of Visits:

4 visits

Length of Study:

Approx. 6 months

Location

Michigan

About Respiratory Syncytial Virus (RSV) & Its Symptoms

Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that affects the lungs and breathing passages. While RSV can resemble a mild cold in healthy individuals, it can lead to severe illness in infants, older adults, and people with weakened immune systems.

Symptoms can vary depending on age and overall health, but may include:

Persistent coughing or wheezing
Difficulty breathing or shortness of breath
Fever and fatigue
Nasal congestion or runny nose
Decreased appetite and irritability in infants

In vulnerable populations, RSV can progress to serious conditions like bronchiolitis or pneumonia, often requiring hospitalization. Because early symptoms can mimic those of a common cold, RSV may go unrecognized until it becomes more severe.

Frequently Asked Questions (FAQs)

Is the RSV clinical trials in Southfield, Michigan for healthy people?

Yes, respiratory syncytial virus clinical trials are enrolling adults aged 60 years and older who are in good general health.

Where will I receive my vaccination?

If eligible, you’ll be invited to visit our clinical site where all study-related procedures, including vaccination, will take place.

What will participants receive in this trial?

Participants will receive a single dose of the investigational RSV clinical trials (RSVpreF). This is an open-label study in the U.S., which means all participants will receive the same vaccine formulation.

How will this RSV vaccine trial benefit you?

By participating, you may:

Receive expert medical care throughout the trial
Help advance vaccine research for RSV prevention in older adults
Gain early access to an investigational respiratory syncytial virus clinical trial
Be eligible for compensation for your time and travel

Is participation in the RSV vaccine trial safe?

Yes, your safety is our top priority. The investigational respiratory syncytial virus treatment has undergone earlier phases of testing. Throughout the study, our medical team will monitor your health closely, track any symptoms, and provide support. You will also be guided by informed consent and made aware of all potential risks and benefits before participating.

How long will my participation in the respiratory syncytial virus clinical trials last?

The study duration is approximately 6 months, with 4 scheduled visits. A small subset of participants may be asked to return for a 12-month follow-up. These visits include safety checks, health monitoring, and blood draws to assess your immune response to the vaccine.

Your contribution supports medical progress that may protect future generations from serious respiratory illness.